Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Surgery
Erhöhte Thrombinbildung und Inzidenz venöser Thromboembolien bei Patient:innen nach zytoreduktiver Chirurgie mit hyperthermer intraperitonealer Chemotherapie im Vergleich zu minimalinvasiver Rektalchirurgie
Thrombosis and Haemostasis · 01.05.2025 · 125 (05) · 460-469
DOI: 10.1055/a-2413-4989 ↗Auf einen Blick
Bei 45 CRS + HIPEC- und 45 MIS-Patient:innen stieg F1 + 2 nach beiden Eingriffen an, stärker nach CRS + HIPEC. Die VTE-Inzidenz innerhalb von 30 Tagen war dort höher.
Fragestellung
Unterscheiden sich Gerinnungs- und Fibrinolyseveränderungen sowie die VTE-Inzidenz innerhalb von 30 Tagen zwischen CRS + HIPEC und MIS?
Methode
Kohortenstudie mit 45 CRS + HIPEC- und 45 MIS-Patient:innen; Blutentnahmen präoperativ, am OP-Ende sowie an POD 1, 3 bis 4 und 5 bis 7; VTE-Screening per Ultraschall an POD 3 bis 7.
Ergebnisse
Der mittlere Anstieg von F1 + 2 vom präoperativen Wert bis zum OP-Ende war bei CRS + HIPEC größer als bei MIS: Δ1.322 [1.040:1.604] pmol/L, p < 0,01. VTE: 24 % vs. 5 %, p = 0,01.
Schlussfolgerung der Autor:innen
F1 + 2 stieg nach beiden Eingriffen an, jedoch deutlich stärker nach CRS + HIPEC. Die VTE-Inzidenz innerhalb von 30 Tagen war bei CRS + HIPEC höher als bei MIS.
Kernaussagen
- F1 + 2-Anstieg nach beiden Eingriffen
- Stärkerer Anstieg nach CRS + HIPEC: Δ1.322 [1.040:1.604] pmol/L
- VTE: 24 % vs. 5 % innerhalb von 30 Tagen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Vergleichsstudie in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.05.2025. Verfasst von Mikkel Lundbech und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Cytoreduction Surgical Procedures, Venous Thromboembolism, Peritoneal Neoplasms, Hyperthermic Intraperitoneal Chemotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Thromboseprophylaxe, Onkologische Pflege
Abstract (Originalsprache)
Surgical treatment of colorectal cancer carries a risk for venous thromboembolism (VTE). We investigated changes in coagulation and fibrinolysis and the VTE incidence within 30 days in patients undergoing open cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) for peritoneal metastases from colorectal cancer and minimally invasive surgery (MIS) for localized rectal cancer. This cohort study included 45 CRS + HIPEC and 45 MIS patients. Blood samples were obtained preoperatively, at the end of surgery, and postoperative day (POD) 1, 3 to 4, and 5 to 7. Systematic ultrasonographic screening for VTE was performed between POD 3 and 7. Computed tomography scan was performed if complications were suspected. The primary endpoint was the difference in mean change (Δ) with [95% confidence intervals] from preoperative to end of surgery in prothrombin fragment 1 + 2 (F1 + 2) levels. Secondary endpoints were the difference in mean change in biomarkers of coagulation and fibrinolysis from preoperative to POD 5 to 7 and the VTE incidence. F1 + 2 levels increased from preoperative to the end of surgery in both groups. The mean increase from preoperative to end of surgery in F1 + 2 levels was significantly greater in CRS + HIPEC patients than MIS patients: Δ1,322 [1,040:1,604] pmol/L, p < 0.01. The VTE incidence was significantly higher after CRS + HIPEC than MIS (24 vs. 5%, p = 0.01). F1 + 2 levels were increased after both procedures, but to a far greater extent following CRS + HIPEC. The VTE incidence within 30 days was significantly higher in patients treated with CRS + HIPEC than in MIS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Plastic and Breast Surgery, Aarhus University Hospital, Aarhus, Denmark.
- Department of Surgery, Aarhus University Hospital, Aarhus, Denmark.
- Department of Anesthesiology South, Aarhus University Hospital, Aarhus, Denmark.
- Department of Radiology, Aarhus University Hospital, Aarhus, Denmark.
Zitieren
APA
Lundbech, M., Krag, A. E., Iversen, L. H., Brandsborg, B., Madsen, N., & Hvas, A. M. (2025). Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Surgery. Thrombosis and Haemostasis, 125(05), 460-469. https://doi.org/10.1055/a-2413-4989
Vancouver
Lundbech M, Krag AE, Iversen LH, Brandsborg B, Madsen N, Hvas AM. Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Surgery. Thrombosis and Haemostasis. 2025;125(05):460-469. doi:10.1055/a-2413-4989
BibTeX
@article{Lundbech2025,
author = {Lundbech, Mikkel and Krag, Andreas E and Iversen, Lene H and Brandsborg, Birgitte and Madsen, Nina and Hvas, Anne-Mette},
title = {Elevated Thrombin Generation and Venous Thromboembolism Incidence in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Compared with Minimally Invasive Rectal Surgery},
journal = {Thrombosis and Haemostasis},
year = {2025},
volume = {125},
number = {05},
pages = {460--469},
doi = {10.1055/a-2413-4989}
}
EUVIMED